FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4285992095> ?p ?o ?g. }

• W4285992095 endingPage "100322" @default.
• W4285992095 startingPage "100322" @default.
• W4285992095 abstract "The pace of the COVID-19 pandemic poses an unprecedented challenge to the evidence-to-decision process. Latin American countries have responded to COVID-19 by introducing interventions to both mitigate the risk of infection and to treat cases. Understanding how evidence is used to inform government-level decision-making at a national scale is crucial for informing country and regional actors in ongoing response efforts. This study was undertaken between February-May 2021 and aims to characterise the best available evidence (BAE) and assess the extent to which it was used to inform decision-making in 21 Latin American countries, in relation to pharmaceutical (PI) and non-pharmaceutical interventions (NPI) related to COVID-19, including the use of therapeutics (corticosteroids, hydroxychloroquine/chloroquine and ivermectin), facemask use in the community setting and the use of diagnostic tests as a requirement for international travel. A three-phase methodology was used to; (i) characterise the BAE for each intervention using an umbrella review, (ii) identify government-level decisions for each intervention through a document review and (iii) assess the use of evidence to inform decisions using a novel adapted framework analysis. The BAE is characterized by 17 living and non-living systematic reviews as evolving, and particularly uncertain for NPIs. 107 country-level documents show variation in both content and timing of decision outcomes across intervention types, with the majority of decisions taken at a time of evidence uncertainty, with only 5 documents including BAE. Seven out of eight key indicators of an evidence-to-decision process were identified more frequently among PIs than either NPI of facemask use or testing prior to travel. Overall evidence use was reported more frequently among PIs than either NPI of facemask use or travel testing (92%, 28% and 29%, respectively). There are limitations in the extent to which evidence use in decision-making is reported across the Latin America region. Institutionalising this process and grounding it in existing and emerging methodologies can facilitate the rapid response in an emergency setting. No funding was sourced for this work." @default.
• W4285992095 created "2022-07-21" @default.
• W4285992095 creator A5020180402 @default.
• W4285992095 creator A5022051713 @default.
• W4285992095 creator A5031573583 @default.
• W4285992095 creator A5038061248 @default.
• W4285992095 creator A5040981901 @default.
• W4285992095 creator A5067702542 @default.
• W4285992095 date "2022-10-01" @default.
• W4285992095 modified "2023-09-25" @default.
• W4285992095 title "Evidence in decision-making in the context of COVID-19 in Latin America" @default.
• W4285992095 cites W1534533078 @default.
• W4285992095 cites W1973787774 @default.
• W4285992095 cites W1995148731 @default.
• W4285992095 cites W2031741091 @default.
• W4285992095 cites W2062246653 @default.
• W4285992095 cites W2071252207 @default.
• W4285992095 cites W2084331111 @default.
• W4285992095 cites W2097381607 @default.
• W4285992095 cites W2111637361 @default.
• W4285992095 cites W2112238768 @default.
• W4285992095 cites W2164401888 @default.
• W4285992095 cites W2291963630 @default.
• W4285992095 cites W2364450135 @default.
• W4285992095 cites W2470058069 @default.
• W4285992095 cites W2560615441 @default.
• W4285992095 cites W2609112051 @default.
• W4285992095 cites W3005383699 @default.
• W4285992095 cites W3011702205 @default.
• W4285992095 cites W3030082895 @default.
• W4285992095 cites W3030991920 @default.
• W4285992095 cites W3031307765 @default.
• W4285992095 cites W3032742287 @default.
• W4285992095 cites W3035860952 @default.
• W4285992095 cites W3036188798 @default.
• W4285992095 cites W3037921181 @default.
• W4285992095 cites W3043359548 @default.
• W4285992095 cites W3043982450 @default.
• W4285992095 cites W3044380668 @default.
• W4285992095 cites W3046396978 @default.
• W4285992095 cites W3082176204 @default.
• W4285992095 cites W3082202055 @default.
• W4285992095 cites W3084268086 @default.
• W4285992095 cites W3085258940 @default.
• W4285992095 cites W3085841760 @default.
• W4285992095 cites W3086318180 @default.
• W4285992095 cites W3106640820 @default.
• W4285992095 cites W3107202290 @default.
• W4285992095 cites W3133221767 @default.
• W4285992095 cites W3135652442 @default.
• W4285992095 cites W3139256117 @default.
• W4285992095 cites W3140313913 @default.
• W4285992095 cites W3159981122 @default.
• W4285992095 cites W3164392163 @default.
• W4285992095 cites W3212343204 @default.
• W4285992095 cites W4205372731 @default.
• W4285992095 cites W4205523030 @default.
• W4285992095 cites W4205601754 @default.
• W4285992095 cites W4205934040 @default.
• W4285992095 cites W4214554725 @default.
• W4285992095 cites W4231113527 @default.
• W4285992095 cites W4250473659 @default.
• W4285992095 doi "https://doi.org/10.1016/j.lana.2022.100322" @default.
• W4285992095 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35879980" @default.
• W4285992095 hasPublicationYear "2022" @default.
• W4285992095 type Work @default.
• W4285992095 citedByCount "0" @default.
• W4285992095 crossrefType "journal-article" @default.
• W4285992095 hasAuthorship W4285992095A5020180402 @default.
• W4285992095 hasAuthorship W4285992095A5022051713 @default.
• W4285992095 hasAuthorship W4285992095A5031573583 @default.
• W4285992095 hasAuthorship W4285992095A5038061248 @default.
• W4285992095 hasAuthorship W4285992095A5040981901 @default.
• W4285992095 hasAuthorship W4285992095A5067702542 @default.
• W4285992095 hasBestOaLocation W42859920951 @default.
• W4285992095 hasConcept C111472728 @default.
• W4285992095 hasConcept C118552586 @default.
• W4285992095 hasConcept C13280743 @default.
• W4285992095 hasConcept C138885662 @default.
• W4285992095 hasConcept C158886217 @default.
• W4285992095 hasConcept C166052673 @default.
• W4285992095 hasConcept C166957645 @default.
• W4285992095 hasConcept C17744445 @default.
• W4285992095 hasConcept C199539241 @default.
• W4285992095 hasConcept C205649164 @default.
• W4285992095 hasConcept C27415008 @default.
• W4285992095 hasConcept C2777526511 @default.
• W4285992095 hasConcept C2778137410 @default.
• W4285992095 hasConcept C2779343474 @default.
• W4285992095 hasConcept C2780665704 @default.
• W4285992095 hasConcept C41895202 @default.
• W4285992095 hasConcept C71924100 @default.
• W4285992095 hasConceptScore W4285992095C111472728 @default.
• W4285992095 hasConceptScore W4285992095C118552586 @default.
• W4285992095 hasConceptScore W4285992095C13280743 @default.
• W4285992095 hasConceptScore W4285992095C138885662 @default.
• W4285992095 hasConceptScore W4285992095C158886217 @default.
• W4285992095 hasConceptScore W4285992095C166052673 @default.

• next